Another -cetrapib fail

don’t fuck with your cholesterol levels.

Dalcetrapib, a CETP inhibitor that raises HDL cholesterol, just failed for Roche:  Effects of dalcetrapib in patients with a recent acute coronary syndrome (Schwartz et al., 2012)

Not surprisingly, as Pfizer’s version also failed 5 years ago:  Effects of of torcetrapib in patients at high risk for coronary events (Barter et al., 2007)

must read –> …if it ain’t broke… 



calories proper



Leave a Reply

Your email address will not be published. Required fields are marked *